Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.0352
Abstract: Purpose Hypofractionated radiotherapy (HypoRT) has recently been implemented in patients with glioblastoma (GBM) receiving concurrent temozolomide. Lymphopenia during treatment (LDT) is considered an important prognostic factor of clinical outcomes for GBM. We aimed to investigate… read more here.
Keywords: moderately hypofractionated; clinical outcomes; outcomes moderately; hypofractionated concurrent ... See more keywords